Publicacions (25) Publicacions de PEDRO GONZALEZ MENENDEZ

2024

  1. Signaling, cancer cell plasticity, and intratumor heterogeneity

    Cell Communication and Signaling

  2. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A

    Blood, Vol. 141, Núm. 20, pp. 2520-2536

  2. Castration promotes the browning of the prostate tumor microenvironment

    Cell communication and signaling : CCS, Vol. 21, Núm. 1, pp. 267

  3. Reflections on the Biology of Cell Culture Models: Living on the Edge of Oxidative Metabolism in Cancer Cells

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase

    Antioxidants, Vol. 11, Núm. 2

  2. Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance

    Haematologica, Vol. 107, Núm. 1, pp. 167-177

  3. Vitamin C deficiency reveals developmental differences between neonatal and adult hematopoiesis

    Frontiers in Immunology, Vol. 13

2021

  1. An IDH1-vitamin C crosstalk drives human erythroid development by inhibiting pro-oxidant mitochondrial metabolism

    Cell Reports, Vol. 34, Núm. 5

  2. Androgen-dependent prostate cancer cells reprogram their metabolic signature upon Glut-1 upregulation by Manganese Superoxide Dismutase (Mnsod/SOD2)

    Free Radical Biology and Medicine, Vol. 165, pp. 53-54

  3. The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis

    Blood, Vol. 137, Núm. 25, pp. 3548-3562

2020

  1. Downregulation of mitochondrial tspo inhibits mitophagy and reduces enucleation during human terminal erythropoiesis

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-15

  2. Melatonin-induced cytoskeleton reorganization leads to inhibition of melanoma cancer cell proliferation

    International Journal of Molecular Sciences, Vol. 21, Núm. 2

2018

  1. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress

    Redox Biology, Vol. 17, pp. 112-127

  2. The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?

    International Journal of Cancer, Vol. 142, Núm. 12, pp. 2414-2424

2017

  1. Accurate and sensitive determination of molar fractions of 13C-Labeled intracellular metabolites in cell cultures grown in the presence of isotopically-labeled glucose

    Analytica Chimica Acta, Vol. 969, pp. 35-48

  2. Cellular uptake and tissue biodistribution of functionalized gold nanoparticles and nanoclusters

    Journal of Biomedical Nanotechnology, Vol. 13, Núm. 2, pp. 167-179

  3. IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer

    Journal of Pineal Research, Vol. 62, Núm. 1

  4. Melatonin and sirtuins: A “not-so unexpected” relationship

    Journal of Pineal Research, Vol. 62, Núm. 2

  5. Melatonin decreases glucose metabolism in prostate cancer cells: A 13C stable isotope-resolved metabolomic study

    International Journal of Molecular Sciences, Vol. 18, Núm. 8